Volume 19 Issue 2
Feb.  2021
Turn off MathJax
Article Contents

doi: 10.16766/j.cnki.issn.1674-4152.001803
  • Received Date: 2020-03-28
    Available Online: 2022-02-19
  • loading
  • [1]
    徐小元, 丁惠国, 李文刚, 等. 肝硬化肝性脑病诊疗指南(2018年, 北京)[J]. 中华胃肠内镜电子杂志, 2018, 5(3): 97-113. https://www.cnki.com.cn/Article/CJFDTOTAL-WCNJ201803001.htm
    [2]
    KRISHNARAO A, GORDON F D. Prognosis of hepatic encephalopathy[J]. Clin Liver Dis, 2020, 24(2): 219-229. doi: 10.1016/j.cld.2020.01.004
    [3]
    MERLI M, BERZIGOTTI A, ZELBER-SAGI S, et al. EASL Clinical practice guidelines on nutrition in chronic liver disease[J]. J Hepatol, 2019, 70(1): 172-193 doi: 10.1016/j.jhep.2018.06.024
    [4]
    侯昀. 肝硬化不同病因上消化道出血患者的临床对比[J]. 临床和实验医学杂志, 2015, 14(12): 999-1001. doi: 10.3969/j.issn.1671-4695.2015.012.014
    [5]
    FALLAHZADEH M A, RAHIMI R S. Hepatic encephalopathy and nutrition influences: A narrative review[J]. Nutr Clin Pract, 2020, 35(1): 36-48. doi: 10.1002/ncp.10458
    [6]
    MOCTEZUMA-VELAZQUEZ C, EBADI M, BHANJI R A, et al. Limited performance of subjective global assessment compared to computed tomography-determined sarcopenia in predicting adverse clinical outcomes in patients with cirrhosis[J]. Clin Nutr, 2019, 38(6): 2696-2703. doi: 10.1016/j.clnu.2018.11.024
    [7]
    MCCLAVE S A, TAYLOR B E, MARTINDALE R G, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition(A.S.P.E.N. )[J]. Jpen-Parenter Enter, 2016, 40(2): 159-211. doi: 10.1177/0148607115621863
    [8]
    SINGER P, BLASER A R, BERGER M M, et al. ESPEN guideline on clinical nutrition in the intensive care unit[J]. Clin Nutr, 2019, 38(1): 48-79. doi: 10.1016/j.clnu.2018.08.037
    [9]
    孙仁华, 江荣林, 黄曼. 重症患者早期肠内营养临床实践专家共识[J]. 中华危重病急救医学, 2018, 30(8): 715-721.
    [10]
    REINTAM BLASER A, STARKOPF J, ALHAZZANI W, et al. Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines[J]. Intens Care Med, 2017, 43(3): 380-398. doi: 10.1007/s00134-016-4665-0
    [11]
    LI Y, ZHUANG S T, YANG M, et al. Bio-statistical analysis of early supplementary parenteral nutrition in critically ill patients[J]. J Med Imag Health In, 2019, 9(5): 940-944. http://www.ingentaconnect.com/contentone/asp/jmihi/2019/00000009/00000005/art00014
    [12]
    GUNST J, VAN DEN BERGHE G. Parenteral nutrition in the critically ill[J]. Curr Opin Crit Care, 2017, 23(2): 149-158. doi: 10.1097/MCC.0000000000000385
    [13]
    CHEN C J, WANG L C, KUO H T, et al. Significant effects of late evening snack on liver functions in patients with liver cirrhosis: A meta-analysis of randomized controlled trials[J]. J Gastroen Hepatol, 2019, 34(7): 1143-1152. doi: 10.1111/jgh.14665
    [14]
    KORNERUP L S, GLUUD L L, VILSTRU H, et al. Update on the therapeutic management of hepatic encephalopathy[J]. Curr Gastroenterol Rep, 2018, 20(5): 21-32. doi: 10.1007/s11894-018-0627-8
    [15]
    GLUUD L L, DAM G B, METTE L, et al. Oral branched-chain amino acids have a beneficial effect on manifestations of hepatic encephalopathy in a systematic review with meta-analyses of randomized controlled trials1, 2[J]. J Nutr, 2013, 143(8): 1263-1268. doi: 10.3945/jn.113.174375
    [16]
    GLUUD L L, DAM G, LES I, et al. Branched-chain amino acids for people with hepatic encephalopathy[J]. Cochrane Database Syst Rev, 2017, 5: 1939-1946. http://www.researchgate.net/profile/Gitte_Dam/publication/272838852_Branched-chain_amino_acids_for_people_with_hepatic_encephalopathy/links/54f414760cf24eb8794d26a5.pdf
    [17]
    SIMON-TALERO M, GARCIA-MARTINEZ R, TORRENS M, et al. Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: a randomized double-blind study[J]. J Hepatol, 2013, 59(6): 1184-1192. doi: 10.1016/j.jhep.2013.07.020
    [18]
    ZUCKER D M, REDULLA R. Lactulose management of minimal hepatic encephalopathy: a systematic review[J]. Gastroenterol Nurs, 2019, 42(1): 84-94. doi: 10.1097/SGA.0000000000000429
    [19]
    SHARMA B C, SINGH J. Probiotics in management of hepatic encephalopathy[J]. Metab Brain Dis, 2016, 31(6): 1295-1301. doi: 10.1007/s11011-016-9826-x
    [20]
    WEIR V, REDDY K R. Nonpharmacologic management of hepatic encephalopathy: an update[J]. Clin liver Dis, 2020, 24(2): 243-261. doi: 10.1016/j.cld.2020.01.003
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(4)

    Article Metrics

    Article views (112) PDF downloads(13) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return